Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Ketamine Treatment

Recent news which mentions Ketamine Treatment

HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion

August 26, 2024

Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More

January 08, 2024

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More

December 05, 2023

Super Model Chrissy Teigen Talks About Ketamine Therapy Session, Says She Saw 'Space & Time'

December 04, 2023

Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans

November 27, 2023

Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions

October 17, 2023

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

October 16, 2023

PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance

September 27, 2023

PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application

September 06, 2023

Breaking Ground In Prevention & Relief Of Anxiety & PTSD: Silo Pharma' Nasal Formulation For Ketamine-Based Treatment

August 08, 2023

Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics

August 01, 2023

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets

June 27, 2023

Silo Pharma's New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making

June 13, 2023

Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History

May 16, 2023

Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?

May 10, 2023

Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations

April 14, 2023

Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval

March 30, 2023

Silo Pharma To Patent Novel Ketamine-Based Treatment For Chronic Condition

March 27, 2023

Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms

March 22, 2023

Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal

March 16, 2023

Awakn's First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics

February 22, 2023

Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials

February 16, 2023

Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program

February 14, 2023

Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy

February 07, 2023

PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch

February 03, 2023

Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results

January 31, 2023

FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder

December 16, 2022

FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status

December 15, 2022

Psychedelic-Assisted Therapies: Upcoming Moves In Montana, Colorado And Ontario

November 22, 2022

This New Psychedelic Therapy Program Will Accompany Patients In Their Healing Journey For A Whole Year

November 15, 2022

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.